retatrutide glucagon effect How Does Work? Triple Agonist Explained Retatrutide, a GIP, GLP-1 and

Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells

The prothrombotic state in atrial fibrillation: Pathophysiological and management implications

As innovations in CRISPR/Cas, excision technologies, and metabolic pathway optimization advance, edible mushrooms could become self-contained biofactories that express, encapsulate, and deliver therapeutic proteins directly through oral routesoffering a sustainable, low-cost alternative to conventional injectable biologics

Timing matters for certain stacks

I think there is no doubt this will elevate GLP-1 receptor agonists in the treatment paradigm, perhaps even above SGLT2 inhibitors, because the benefit on mortality is substantial, Pratley told Healio | Endocrine Today